Work

AlphaFold Shock: Innovation Reallocation in Structural-Biology Firms

Type: article
Abstract: AlphaFold is a domain-specific AI that addresses a key bottleneck in early-stage drug discovery: predicting protein structures. Such a breakthrough might intuitively be expected to accelerate upstream innovation and alter how firms allocate innovation across the R&D pipeline. Prior studies mainly examine general-purpose AI or innovation outputs within a single R&D stage. Less is known about how firms shift innovation focus when domain-specific AI breaks through an industry’s core technology. Using the AlphaFold shock as a natural experiment, we construct patent-based measures of upstream and downstream R&D activities for structural biology firms and estimate a difference-in-differences model. Our results reveal a non-intuitive finding: both patent applications and granted patents decrease after the shock. Meanwhile, firms shift innovation focus from upstream drug discovery toward downstream stages closer to clinical trials and commercialization. These findings extend AI innovation research and inform biotech strategy and innovation policy.
Language: English
Open Access status: green
OpenAlex ID: W7222989992
Cites: 24
Cited by:
Related to: 10